mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.004 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.005 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.005 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.007 |